FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123625375> ?p ?o ?g. }

• W2123625375 endingPage "333.e1" @default.
• W2123625375 startingPage "325" @default.
• W2123625375 abstract "Objective To study the prevalence of ocular manifestations in African American and Caucasian patients with biopsy-proven sarcoidosis at the initial ophthalmic examination and to determine the relationship between angiotensin-converting enzyme (ACE) levels, chest x-ray findings, and ocular signs of sarcoidosis. Design Retrospective, cross-sectional, observational study. Participants Eighty-one consecutive patients with biopsy-proven sarcoidosis seen at the Doheny Eye Institute from January 1989 through April 2005. Methods Medical records were reviewed to obtain demographic data, biopsy site, initial ocular findings, pulmonary symptoms, and results of serum ACE levels and chest x-rays. Associations between ACE level/chest x-ray stages and ocular manifestations related to sarcoidosis were obtained from these data. Main Outcome Measures Ocular manifestations related to sarcoidosis. Results Of the 81 patients, 35 were Caucasian; 29 were African American; and the remaining 17 were Hispanic, Asian Indian, and other races. Female patients were older than males (P = 0.05). Sixty-five (80%) of the 81 patients had ocular manifestations related to sarcoidosis. Thirty-three patients (40.7%) had uveitis, 12 (14.8%) had adnexal granulomas, and 25 (30.8%) had keratoconjunctivitis sicca. Of the 33 patients with uveitis, 22 presented with nongranulomatous inflammation. There was no significant association between ocular manifestations related to sarcoidosis and serum ACE levels (P = 0.43) or chest x-ray stage (P>0.99). Of the 29 African American patients, 26 (89.7%) had ocular manifestations related to sarcoidosis, compared with 24 (68.6%) of the 35 Caucasians (P = 0.12). The African American patients were younger (mean age, 44.4 years) than the Caucasian patients (mean age, 52.0) (P = 0.003) and had higher mean ACE levels (P = 0.003). A significantly high proportion of African American males presented with uveitis (P = 0.005), and a significantly high proportion of African American females presented with adnexal granulomas (P = 0.05). Conclusions The present study reveals that patients with sarcoidosis can present initially with clinical features of nongranulomatous uveitis. Relative to Caucasians, African American patients with sarcoidosis tend to be younger when they first present to the ophthalmologist and to present with uveitis and/or adnexal granuloma. Serum ACE levels and chest x-ray stages may not help predict the occurrence of ocular changes in sarcoidosis. To study the prevalence of ocular manifestations in African American and Caucasian patients with biopsy-proven sarcoidosis at the initial ophthalmic examination and to determine the relationship between angiotensin-converting enzyme (ACE) levels, chest x-ray findings, and ocular signs of sarcoidosis. Retrospective, cross-sectional, observational study. Eighty-one consecutive patients with biopsy-proven sarcoidosis seen at the Doheny Eye Institute from January 1989 through April 2005. Medical records were reviewed to obtain demographic data, biopsy site, initial ocular findings, pulmonary symptoms, and results of serum ACE levels and chest x-rays. Associations between ACE level/chest x-ray stages and ocular manifestations related to sarcoidosis were obtained from these data. Ocular manifestations related to sarcoidosis. Of the 81 patients, 35 were Caucasian; 29 were African American; and the remaining 17 were Hispanic, Asian Indian, and other races. Female patients were older than males (P = 0.05). Sixty-five (80%) of the 81 patients had ocular manifestations related to sarcoidosis. Thirty-three patients (40.7%) had uveitis, 12 (14.8%) had adnexal granulomas, and 25 (30.8%) had keratoconjunctivitis sicca. Of the 33 patients with uveitis, 22 presented with nongranulomatous inflammation. There was no significant association between ocular manifestations related to sarcoidosis and serum ACE levels (P = 0.43) or chest x-ray stage (P>0.99). Of the 29 African American patients, 26 (89.7%) had ocular manifestations related to sarcoidosis, compared with 24 (68.6%) of the 35 Caucasians (P = 0.12). The African American patients were younger (mean age, 44.4 years) than the Caucasian patients (mean age, 52.0) (P = 0.003) and had higher mean ACE levels (P = 0.003). A significantly high proportion of African American males presented with uveitis (P = 0.005), and a significantly high proportion of African American females presented with adnexal granulomas (P = 0.05). The present study reveals that patients with sarcoidosis can present initially with clinical features of nongranulomatous uveitis. Relative to Caucasians, African American patients with sarcoidosis tend to be younger when they first present to the ophthalmologist and to present with uveitis and/or adnexal granuloma. Serum ACE levels and chest x-ray stages may not help predict the occurrence of ocular changes in sarcoidosis." @default.
• W2123625375 created "2016-06-24" @default.
• W2123625375 creator A5025510000 @default.
• W2123625375 creator A5049801898 @default.
• W2123625375 creator A5057119014 @default.
• W2123625375 creator A5079994412 @default.
• W2123625375 creator A5081668399 @default.
• W2123625375 date "2007-02-01" @default.
• W2123625375 modified "2023-10-02" @default.
• W2123625375 title "Differences in Clinical Findings between Caucasians and African Americans with Biopsy-Proven Sarcoidosis" @default.
• W2123625375 cites W1977272171 @default.
• W2123625375 cites W1981494136 @default.
• W2123625375 cites W2002275298 @default.
• W2123625375 cites W2016746914 @default.
• W2123625375 cites W2017932993 @default.
• W2123625375 cites W2024898807 @default.
• W2123625375 cites W2030279957 @default.
• W2123625375 cites W2030807353 @default.
• W2123625375 cites W2032636851 @default.
• W2123625375 cites W2047371155 @default.
• W2123625375 cites W2070310010 @default.
• W2123625375 cites W2077128340 @default.
• W2123625375 cites W2079246288 @default.
• W2123625375 cites W2082186503 @default.
• W2123625375 cites W2083410097 @default.
• W2123625375 cites W2084744909 @default.
• W2123625375 cites W2117839092 @default.
• W2123625375 cites W2120146300 @default.
• W2123625375 cites W2138676597 @default.
• W2123625375 cites W2139499737 @default.
• W2123625375 cites W2149236748 @default.
• W2123625375 cites W4212811626 @default.
• W2123625375 doi "https://doi.org/10.1016/j.ophtha.2006.05.074" @default.
• W2123625375 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17123620" @default.
• W2123625375 hasPublicationYear "2007" @default.
• W2123625375 type Work @default.
• W2123625375 sameAs 2123625375 @default.
• W2123625375 citedByCount "112" @default.
• W2123625375 countsByYear W21236253752012 @default.
• W2123625375 countsByYear W21236253752013 @default.
• W2123625375 countsByYear W21236253752014 @default.
• W2123625375 countsByYear W21236253752015 @default.
• W2123625375 countsByYear W21236253752016 @default.
• W2123625375 countsByYear W21236253752017 @default.
• W2123625375 countsByYear W21236253752018 @default.
• W2123625375 countsByYear W21236253752019 @default.
• W2123625375 countsByYear W21236253752020 @default.
• W2123625375 countsByYear W21236253752021 @default.
• W2123625375 countsByYear W21236253752022 @default.
• W2123625375 countsByYear W21236253752023 @default.
• W2123625375 crossrefType "journal-article" @default.
• W2123625375 hasAuthorship W2123625375A5025510000 @default.
• W2123625375 hasAuthorship W2123625375A5049801898 @default.
• W2123625375 hasAuthorship W2123625375A5057119014 @default.
• W2123625375 hasAuthorship W2123625375A5079994412 @default.
• W2123625375 hasAuthorship W2123625375A5081668399 @default.
• W2123625375 hasConcept C118487528 @default.
• W2123625375 hasConcept C126322002 @default.
• W2123625375 hasConcept C16005928 @default.
• W2123625375 hasConcept C167135981 @default.
• W2123625375 hasConcept C195910791 @default.
• W2123625375 hasConcept C2775934546 @default.
• W2123625375 hasConcept C2776194053 @default.
• W2123625375 hasConcept C2778674544 @default.
• W2123625375 hasConcept C2780648854 @default.
• W2123625375 hasConcept C2781301800 @default.
• W2123625375 hasConcept C71924100 @default.
• W2123625375 hasConceptScore W2123625375C118487528 @default.
• W2123625375 hasConceptScore W2123625375C126322002 @default.
• W2123625375 hasConceptScore W2123625375C16005928 @default.
• W2123625375 hasConceptScore W2123625375C167135981 @default.
• W2123625375 hasConceptScore W2123625375C195910791 @default.
• W2123625375 hasConceptScore W2123625375C2775934546 @default.
• W2123625375 hasConceptScore W2123625375C2776194053 @default.
• W2123625375 hasConceptScore W2123625375C2778674544 @default.
• W2123625375 hasConceptScore W2123625375C2780648854 @default.
• W2123625375 hasConceptScore W2123625375C2781301800 @default.
• W2123625375 hasConceptScore W2123625375C71924100 @default.
• W2123625375 hasIssue "2" @default.
• W2123625375 hasLocation W21236253751 @default.
• W2123625375 hasLocation W21236253752 @default.
• W2123625375 hasOpenAccess W2123625375 @default.
• W2123625375 hasPrimaryLocation W21236253751 @default.
• W2123625375 hasRelatedWork W1975834265 @default.
• W2123625375 hasRelatedWork W1977272171 @default.
• W2123625375 hasRelatedWork W1977615989 @default.
• W2123625375 hasRelatedWork W1986839945 @default.
• W2123625375 hasRelatedWork W1990640980 @default.
• W2123625375 hasRelatedWork W2017932993 @default.
• W2123625375 hasRelatedWork W2102013155 @default.
• W2123625375 hasRelatedWork W2553005515 @default.
• W2123625375 hasRelatedWork W2952107501 @default.
• W2123625375 hasRelatedWork W2979211307 @default.
• W2123625375 hasVolume "114" @default.
• W2123625375 isParatext "false" @default.
• W2123625375 isRetracted "false" @default.
• W2123625375 magId "2123625375" @default.
• W2123625375 workType "article" @default.